Breast Cancer Clinical Trials in Toledo
2 recruitingToledo, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 3
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Greenwich LifeSciences, Inc.750 enrolled161 locationsNCT05232916
Recruiting
Phase 4
The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage
Breast CancerHemopatchAxillary Lymphadenectomy
Instituto de Investigación Hospital Universitario La Paz118 enrolled1 locationNCT04904653